Gennbio

Gennbio Inc builds drug and bio long-term development platform. The company produces models of primate diseases such as organ transplants and immune or diabetic models.

Sungjoo Kim

CEO

1 past transactions

MEDIUM

Seed Round in 2020
Medium is a block chain specialist that develops block chain solutions to respond to the commercial enterprise market with its own block chain technology. In order to overcome the limitations on performance, which is an impediment to blockchain commercialization, we have the best global blockchain solutions through the development of technology that breaks the framework of thinking, such as blockchain core and blockchain dedicated hardware. It is a company that conducts R&D and collaboration with leading companies.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.